CareDx Inc reports results for the quarter ended June 30 - Earnings Summary

CareDx

31/07/2026 06:50

CareDx Inc CDNA.OQ reported quarterly adjusted earnings of 37 cents​​ per share for the quarter ended June 30, higher than the same quarter last year, when the company reported EPS of 10 cents.  The mean expectation of seven analysts for the quarter was for earnings of 23 cents per share. Wall Street expected results to range from 20 cents to 27 cents per share.
Revenue rose 52.2% to $131.95 million from a year ago; analysts expected $114.04 million. 
CareDx Inc's reported EPS for the quarter was $2.07​.
The company reported quarterly net income of $110.64 million.
CareDx Inc shares had risen by 33.7% this quarter and gained 102.2% so far this year.
FORECAST CHANGES
The mean earnings estimate of analysts had fallen by about 1.9% in the last three months.​ 
In the last 30 days, there have been no earnings estimate revisions by analysts covering the company.
RECOMMENDATIONS
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," 4 "hold" and no "sell" or "strong sell." The average consensus recommendation for the biotechnology & medical research peer group is also "buy" 
Wall Street's median 12-month price target for CareDx Inc is $35.00, about 8.9% below its last closing price of $38.10
This summary was machine generated from LSEG data July 31 at 05:50 a.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)
QUARTER ENDING
ESTIMATE 
ACTUAL
BEAT, MET, MISSED
Jun. 30 2026 
0.23
0.37
Beat
Mar. 31 2026 
0.13
0.34
Beat
Dec. 31 2025 
0.24
0.12
Missed
Sep. 30 2025 
0.14
0.28
Beat